What does Safeguard Scientifics invest in?
Safeguard Scientifics invests most often at Series B and Series A (66% of the rounds on record), in sectors such as Telehealth, Health-tech and Wellness.
United States · Investor
Last cheque observed May 2023. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.
QuietPrivate equityWebsite unconfirmed
85 rounds on record
Mostly Series B and Series A: 66% of its rounds
Sole investor in 21 rounds, median $6.0M
17 exits from the portfolio
A website was listed for this organisation, but we could not confirm it belongs to the firm that wrote these cheques. Either the site never mentions them, or it turned out to be a different company sharing the name. We show neither it nor anything read from it. Tell us the right one.
Every round we can evidence, newest first85 appearances
1 round
4 rounds
6 rounds
11 rounds
9 rounds
8 rounds
5 rounds
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
We hold 15 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
Companies it backed that were later bought or listed17 in all
An exit counts when it came after the firm's first round in the company. From historical deal records.
Acquisitions by the firm itself
The investors most often in the same rounds as Safeguard Scientifics. A count of rooms they were both in, not a relationship either has claimed.
The latest companies Safeguard Scientifics put money into.
Safeguard Scientifics invests most often at Series B and Series A (66% of the rounds on record), in sectors such as Telehealth, Health-tech and Wellness.
85 investments on record, 0 of them in the last 12 months, and it led 2. The most recent was in May 2023.
Its most recent investments on record: Prognos Health (Growth, May 2023), Syapse (Series D, Nov 2017) and Trice Medical (Series C, Jun 2017).
The median round it joins is $11M. It says it writes cheques of $2.0M to $15M.
Sometimes: it led 2 of its 85 investments on record (2%).
Most of the companies it backs are in the United States (100%).
No investments in the last 12 months; the latest was in May 2023.
Most often Constellation Ventures (4 rounds together), Merck Global Health Innovation Fund (4 rounds together) and BioAdvance (3 rounds together).
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it